APA

Heath E., Heilbrun L., Mannuel H., Liu G., Lara P., Monk J. P., Flaig T., Zurita A., Mack P., Vaishampayan U., Stella P., Smith D., Bolton S., Hussain A., Al-Janadi A., Silbiger D., Usman M. & Ivy S. P. (20200727). Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy-Naive Metastatic Castrate-Resistant Prostate Cancer. : The oncologist.

Chicago

Heath Elisabeth, Heilbrun Lance, Mannuel Heather, Liu Glenn, Lara Primo, Monk J Paul, Flaig Thomas, Zurita Amado, Mack Philip, Vaishampayan Ulka, Stella Philip, Smith Daryn, Bolton Susan, Hussain Arif, Al-Janadi Anas, Silbiger Daniel, Usman Muhammad and Ivy S Percy. 20200727. Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy-Naive Metastatic Castrate-Resistant Prostate Cancer. : The oncologist.

Harvard

Heath E., Heilbrun L., Mannuel H., Liu G., Lara P., Monk J. P., Flaig T., Zurita A., Mack P., Vaishampayan U., Stella P., Smith D., Bolton S., Hussain A., Al-Janadi A., Silbiger D., Usman M. and Ivy S. P. (20200727). Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy-Naive Metastatic Castrate-Resistant Prostate Cancer. : The oncologist.

MLA

Heath Elisabeth, Heilbrun Lance, Mannuel Heather, Liu Glenn, Lara Primo, Monk J Paul, Flaig Thomas, Zurita Amado, Mack Philip, Vaishampayan Ulka, Stella Philip, Smith Daryn, Bolton Susan, Hussain Arif, Al-Janadi Anas, Silbiger Daniel, Usman Muhammad and Ivy S Percy. Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy-Naive Metastatic Castrate-Resistant Prostate Cancer. : The oncologist. 20200727.